Faeth Therapeutics FTH
NASDAQ FTH
$21.62 +0.83 (+3.99%)
As of: Oct 21, 2026 · 10:39 AM EDT

Faeth Therapeutics (FTH) Shares Repurchased (2023)

Updated

Analysis

Faeth Therapeutics (FTH) Shares Repurchased (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 221.00 Mn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn 9.00 Mn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn -
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn -
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn 355.00 Mn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn -
10 Faeth Therapeutics 122.01 Mn -313.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 252,000.00
Sep 30, 2023 2.34 Mn
API Access

Faeth Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=FTH&period=max&api_key=YOUR_API_KEY